Company: HVIIR
Filing Date: 2025-12-23
Form Type: S-4
Source: 0001493152-25-029121
Chunk: 122

Company: Hennessy Capital Investment Corp. VII
Filing Date: 2025-12-23
Form: S-4
Chunk 122
---
 deem relevant at the time of purchase. The price per share paid in any such transaction may be different than, but not higher than, the amount per share a HVII Public Shareholder would receive if it elected to redeem its shares in connection with the Business Combination. The Sponsor or HVII’s officers, directors, advisors, or any of their respective affiliates will purchase shares only if such purchases comply with Regulation M under the Exchange Act and the other federal securities laws.

Entering into any such arrangements may have an adverse effect on the price of HVII’s and New ONE Nuclear’s securities. For example, as a result of these arrangements, an investor or holder may have the ability to effectively purchase shares at a price lower than market price and may therefore be more likely to sell the shares he owns, either prior to or immediately after the special meeting.

HVII Public Shareholders will experience immediate dilution as a consequence of the issuance of shares of New ONE Nuclear Common Stock as consideration in the Business Combination and due to future issuances pursuant to the Incentive Plan and the HVII Rights. Having a minority stock ownership position may reduce the influence that current HVII Shareholders have on the management of New ONE Nuclear.

HVII Public Shareholders who do not redeem their HVII Class A Ordinary Shares will experience immediate dilution as a consequence of the issuance of shares of New ONE Nuclear Common Stock as consideration in the Business Combination and may experience dilution from several additional sources to varying degrees in connection with and after the Business Combination, including the following:

| ● | Approximately                                                                                     
 96.7 million shares of New ONE Nuclear Common Stock are anticipated to be issued as consideration 
 in the Business Combination, valued at $10.34 per share (based on amount in the Trust Account     
 as of November 30, 2025, net of accrued taxes). This represents approximately 77.9% or 92.0%      
 of the number of shares of New ONE Nuclear Common Stock that will be outstanding following        
 the consummation of the Business Combination, assuming the No Redemption Scenario and the         
 Maximum Redemption Scenario, respectively; and                                                    |

| ● | New                                                                                           
 ONE Nuclear will reserve [   ]% of the number of outstanding shares of New ONE Nuclear Common 
 Stock (as of immediately following the Business Combination) pursuant to the Incentive Plan   
 and expects to grant equity awards under the Incentive Plan. The granted awards, when vested  
 and settled or exercisable, may result in the issuance of additional shares up to the amount